Welcoming Biotech Executive Cathy Friedman to GV @googleventures
Welcoming Biotech Executive Cathy Friedman to GV  @googleventures
Uploaded January 2022 | Updated November 2026, 3 hours ago
At GV, we often talk about the power of long-term relationships and the importance of building broad, deep networks. We operate in a team environment, share common values, and have a genuine mission to put people and patients first. That's why I'm especially excited to announce healthcare and finance industry veteran Cathy Friedman as our newest Executive Venture Partner

Cathy is not only a phenomenal human who has known members of our team for 30 years; she's also a world-class business executive with nearly 40 years of experience across banking, technology, and life sciences. Cathy comes to GV as an independent financial consultant and board member. Previously, she was a managing director and co-head of the biotech practice at Morgan Stanley, where she spent nearly 24 years.

Read more: gv.com/news/cathy-friedman

0:00 Intro
0:18 Welcoming Cathy Friedman
0:46 Why GV?
2:00 Backstory
3:33 What Is An Executive Venture Partner?
6:02 Market Differences
7:41 Current Market Conditions
10:25 What Leadership Characteristics Do You Look For?
19:14 Growing GV Life Sciences
Welcoming Biotech Executive Cathy Friedman to GVVaccitech Co-Founder Professor Adrian Hill on Developing a Covid-19 VaccineMeet ReserveBehind the scenes: Design sprint with Gimlet MediaTalent Talks: No Bad Hires with Metaview’s Siadhal MagosStartup Lab workshop: Workspace designOne Medical Group’s StoryBetter Wings: Why We Invested in Flapping Airplanes #aiSprint: FridayHow AI Gets Smart: Insights on Models, Markets, and Hurdles from DeepMindS4E4: Moravec’s Paradox and the Evolution of Surgical RoboticsInvestors Tyson Clark and Sydney Sykes on Championing Diversity in Venture Capital
GV (Google Ventures) |

Welcoming Biotech Executive Cathy Friedman to GV

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER